Quarterly Short-term Investments rose 1.41% to $1.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 1.41% year-over-year, with the annual reading at $1.6 billion for FY2025, 1.41% up from the prior year.
Short-term Investments hit $1.6 billion in Q4 2025 for CRISPR Therapeutics AG, roughly flat from $1.6 billion in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $1.7 billion in Q3 2024 to a low of $680.1 million in Q1 2021.
Historically, Short-term Investments has averaged $1.4 billion across 5 years, with a median of $1.5 billion in 2024.
Biggest five-year swings in Short-term Investments: skyrocketed 351.61% in 2021 and later decreased 18.66% in 2023.
Year by year, Short-term Investments stood at $1.5 billion in 2021, then rose by 10.12% to $1.6 billion in 2022, then fell by 18.66% to $1.3 billion in 2023, then rose by 23.11% to $1.6 billion in 2024, then increased by 1.41% to $1.6 billion in 2025.
Business Quant data shows Short-term Investments for CRSP at $1.6 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.5 billion in Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value